Encompass Health Slides 4.8% as Investors Appear to Pull Back Ahead of Earnings
Investivoq PriceTracker
Encompass Health (EHC) is down 4.8% today. Here is some analysis on what might have caused this price movement. ([stocktitan.net](https://www.stocktitan.net/news/EHC/?utm_source=openai))
Analysis: A clear company-specific negative catalyst was not easy to confirm today. This could be because investors are taking profits and trimming exposure ahead of Encompass Health’s late-October earnings report, even as the company continues to post routine operational updates and expansion news. ([encompasshealth.com](https://www.encompasshealth.com/press-releases/encompass-health-announces-date-of-2026-third-quarter-earnings-call?utm_source=openai))
Details:
Sources:
Encompass Health, SEC, Stock Analysis, Benzinga
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$EHC Insider Trading Activity
$EHC insiders have traded $EHC stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EHC stock by insiders over the last 6 months:
- MARK J TARR (President & CEO) has made 0 purchases and 2 sales selling 173,148 shares for an estimated $21,724,095.
- DOUGLAS E COLTHARP (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 46,563 shares for an estimated $5,324,345.
- JOHN PATRICK DARBY (EVP, Gen Counsel & Secretary) has made 0 purchases and 2 sales selling 13,764 shares for an estimated $1,709,965.
- ANDREW L PRICE (Chief Accounting Officer) sold 5,211 shares for an estimated $630,166
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$EHC Hedge Fund Activity
We have seen 273 institutional investors add shares of $EHC stock to their portfolio, and 258 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 2,224,997 shares (-65.7%) from their portfolio in Q2 2026, for an estimated $224,902,696
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,720,246 shares (-94.9%) from their portfolio in Q2 2026, for an estimated $173,882,465
- JPMORGAN CHASE & CO added 1,133,561 shares (+inf%) to their portfolio in Q2 2026, for an estimated $114,580,345
- EVERSEPT PARTNERS, LP added 832,815 shares (+429.1%) to their portfolio in Q2 2026, for an estimated $84,180,940
- HOLOCENE ADVISORS, LP added 827,311 shares (+550.4%) to their portfolio in Q2 2026, for an estimated $83,624,595
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 688,264 shares (+inf%) to their portfolio in Q2 2026, for an estimated $69,569,725
- JANE STREET GROUP, LLC added 578,336 shares (+13576.0%) to their portfolio in Q2 2026, for an estimated $58,458,202
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$EHC Price Targets
Multiple analysts have issued price targets for $EHC recently. We have seen 2 analysts offer price targets for $EHC in the last 6 months, with a median target of $132.5.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $125.0 on 05/28/2026
- Andrew Mok from Barclays set a target price of $140.0 on 05/05/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.